RxDoctor Payments DataLook up a doctor →

Grazia Aleppo, MD

Endocrinology, Diabetes & Metabolism · Chicago, ILNPI 1689603268

Payments from drug & device makers

$1,370,902in general payments, 2019–2025

Across 250 payments — averaging $5483.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tandem Diabetes Care, Inc.$313K
  • AbbVie$261K
  • Insulet Corporation$220K
  • Eli Lilly$190K
  • Dexcom, Inc.$162K
  • Mannkind Corporation$137K
  • plus $88K from 7 others
$4,791in research payments, 2019–2025

Across 9 payments — averaging $532.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Dexcom, Inc.$4K
  • Sequel Med Tech, LLC$450
  • AbbVie$192
  • Eli Lilly$150

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Tandem Diabetes Care, Inc.4$313,108
AbbVie14$260,774
Insulet Corporation37$220,406
Eli Lilly30$189,903
Dexcom, Inc.102$161,798
Mannkind Corporation12$137,292
Bayer25$51,618
Novo Nordisk AS8$32,189
Medtronic9$3,050
Novo Nordisk5$317
Sanofi-aventis U.S. LLC2$269
Intuity Medical Inc1$107
Merck1$69

How this compares

$1,370,902 in reported general payments places this provider in the 95th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.

See all endocrinology, diabetes & metabolism providers in Illinois

Medicare billing

Part B allowed, 2024
$73,183
Medicare patients
248
Services billed
1,193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →